Treatment of a stage III rima glottidis patient with the oncolytic virus Rigvir
Guna Proboka(Creative Commons), Pēteris Alberts(Maxygen (United States)), Andra Tilgase, Agnija Rasa, Sergejs Isajevs(Riga East University Hospital), Evija Olmane(Pauls Stradiņš Clinical University Hospital)
Cited by 3
Related Papers
Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Improves Hepatic Insulin Sensitivity in Hyperglycemic Mice Strains
|Endocrinology|2003|263
Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice
|Diabetologia|2002|259
Arylsulfonamidothiazoles as a New Class of Potential Antidiabetic Drugs. Discovery of Potent and Selective Inhibitors of the 11β-Hydroxysteroid Dehydrogenase Type 1
|Journal of Medicinal Chemistry|2002|211
The advent of oncolytic virotherapy in oncology: The Rigvir® story
|European Journal of Pharmacology|2018|179